Clinical evaluation of pioglitazone in patients with type 2 diabetes using alpha-glucosidase inhibitor and examination of its efficacy profile.

Y Hayashi; N Miyachi; T Takeuchi; Y Takeuchi; F Kamiya; T Kato; K Imaeda; N Okayama; M Shimizu; M Itoh

doi:10.1046/j.1463-1326.2003.00244.x

Clinical evaluation of pioglitazone in patients with type 2 diabetes using alpha-glucosidase inhibitor and examination of its efficacy profile.

Identifier:nobleid.org/w1/20260515/FECAF6AC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FECAF6AC.svg?ark=w1%2F20260515%2FFECAF6AC)](https://nobleid.org/work/w1/20260515/FECAF6AC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Clinical evaluation of pioglitazone in patients with type 2 diabetes using alpha-glucosidase inhibitor and examination of its efficacy profile.

Identifier:nobleid.org/w1/20260515/FECAF6AC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FECAF6AC.svg?ark=w1%2F20260515%2FFECAF6AC)](https://nobleid.org/work/w1/20260515/FECAF6AC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work